Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Oorithalthaamarai Chooranam: 30 mg/kg/BW/twice a day A/F
90 Days
Control Intervention1: NIL: NIL
Sponsors
OPD and IPD facilities and Central Library Government Siddha Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Type 2 diabetes mellitus 2. If yes in any of three As per ADA a. FBS - > 126mg/dl and b. PPBS - >140mg/d land c. HbA1c > 6.5 3. Secondary hyperlipidemia, Dyslipidemia has values as per NCEP a. Total cholesterol - >199 mg/dl or b. LDL - >100-129mg/dl or c. Triglycerides - >150-199 mg/dl. d. HDL level - 4. Willing to give blood sample for the investigations
Exclusion criteria
Exclusion criteria: 1.If yes in any one of three a. FBS - b. PPBS - 2.High lipid profile, dyslipidemia has values of, a. Total cholesterol b. LDL c. Triglycerides d. HDL level ->=50-60 mg /dl 3.Type 1 diabetes mellitus 4.Severe Hypertension 5.Pregnancy 6.Lactating mother 7.Chronic kidney disease / Renal failure 8.Chronic active viral hepatitis/cirrhosis/ascites
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| During treatment or after treatment, FBS became 110mg /dl & PPBS160mg/dl and HbA1c 6.5. Total cholesterol 199 mg/dl, LDL 159 mg/ dl and Triglycerides 150 mg/dl Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Evaluation of safety profile for acute& sub acute toxicity of the trial drug. 2.Evaluation of primary phytochemical analysis in different solvents. 3.Evaluation of pharmacological activities including anti-oxidant property of the trial drug. 4.Evaluation of anti microbial activity in different solvents of the clinical trial drug. 5.To develop clinical documents and literary evidence to support the effect of trial drug. Timepoint: 90 days | — |
Countries
India
Contacts
Public ContactDr A Manoharan MD PhD
Government Siddha Medical College and Hospital Palayamkottai
Outcome results
None listed